These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37021341)

  • 1. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures,
    Nisar M; Gondal HY; Cheema ZM; Yousaf S; Nadeem H
    J Biomol Struct Dyn; 2023; 41(24):15535-15548. PubMed ID: 37021341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
    Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
    J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease.
    Conger N; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA
    J Mol Recognit; 2023 Dec; 36(12):e3059. PubMed ID: 37723924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Evaluation of Novel 2
    Haji Ali S; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O; Kose M
    J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors.
    Abdalla Ali A; Mhamad SA; Hasan AH; Ahmad I; Abdullah SA; Jamil S; Patel H; Murugesan S; Jamalis J
    J Biomol Struct Dyn; 2024 Apr; 42(7):3604-3615. PubMed ID: 37293930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in silico and in vitro studies of hydrazide-hydrazone imine derivatives as potential cholinesterase inhibitors.
    Güngör SA
    Chem Biol Drug Des; 2023 Oct; 102(4):676-691. PubMed ID: 37258044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
    Koly HK; Sutradhar K; Rahman MS
    J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
    Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study.
    Homoud ZA; Taha M; Rahim F; Iqbal N; Nawaz M; Farooq RK; Wadood A; Alomari M; Islam I; Algheribe S; Rehman AU; Khan KM; Uddin N
    J Biomol Struct Dyn; 2023 Nov; 41(19):9865-9878. PubMed ID: 36404604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
    Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
    J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
    Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
    Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
    Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
    Rodríguez-Lavado J; Gallardo-Garrido C; Mallea M; Bustos V; Osorio R; Hödar-Salazar M; Chung H; Araya-Maturana R; Lorca M; Pessoa-Mahana CD; Mella-Raipán J; Saitz C; Jaque P; Reyes-Parada M; Iturriaga-Vásquez P; Pessoa-Mahana H
    Eur J Med Chem; 2020 Jul; 198():112368. PubMed ID: 32388114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.